• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

40岁前发展至肾衰竭的常染色体显性多囊肾病患者的特征

Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40.

作者信息

Wigerinck Stijn, Schellekens Pieter, Smith Byron H, Hanna Christian, Dachy Angelique, Chedid Maroun, Borghol Abdul Hamid, Senum Sarah R, Bockenhauer Detlef, Harris Peter C, Jouret Francois, Bammens Bert, Chebib Fouad T, Mekahli Djalila

机构信息

PKD Research Group, Laboratory of Ion Channel Research, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.

出版信息

Pediatr Nephrol. 2025 Jun;40(6):1997-2007. doi: 10.1007/s00467-024-06652-7. Epub 2025 Feb 1.

DOI:10.1007/s00467-024-06652-7
PMID:39891678
Abstract

BACKGROUND

Autosomal dominant polycystic kidney disease (ADPKD) demonstrates broad genetic and phenotypic variability, with kidney failure (KF) occurring across a wide age spectrum. Despite several predictor tools, there remains a need to identify factors associated with rapid disease progression. This study describes the phenotypic characteristics of a multicentric cohort experiencing early-onset KF by age 40.

METHODS

This retrospective, multicenter cohort study analyzed longitudinal data of rapidly progressive ADPKD patients (n = 199). The prevalence of established risk factors was compared to nine existing ADPKD cohorts (n = 6782) with KF after 40 years of age. We examined the longitudinal impact of early hypertension and urological events on the risk of developing KF.

RESULTS

The median age at ADPKD diagnosis was 22.3 years (IQR, 16.5-28.6) and median age of KF was 35.6 years (31.7-38.0). Hypertension was observed in 68.1% of cases, with early-onset hypertension being more common among those with accelerated progression towards KF. Urological events were present in 60.1% of cases, with a high burden of gross hematuria (30.4%). Existing ADPKD cohorts had a mean age of 45.5 years, with weighted prevalences of hypertension (71.1%), kidney stones (22.4%), hematuria (22.9%), and urinary tract infections (22.8%). Extrarenal manifestations were less prevalent compared to other ADPKD cohorts.

CONCLUSION

This study outlines a cohort of ADPKD patients with accelerated disease progression, reaching KF before age 40. Hypertension and urological events were highly prevalent at a young age, emphasizing the importance of early and regular blood pressure monitoring.

摘要

背景

常染色体显性多囊肾病(ADPKD)具有广泛的遗传和表型变异性,肾衰竭(KF)可发生在较宽的年龄范围内。尽管有几种预测工具,但仍需要确定与疾病快速进展相关的因素。本研究描述了一个多中心队列中40岁前出现早发性肾衰竭的患者的表型特征。

方法

这项回顾性多中心队列研究分析了快速进展性ADPKD患者(n = 199)的纵向数据。将已确定的风险因素的患病率与9个现有的ADPKD队列(n = 6782)进行比较,这些队列中的患者在40岁后出现肾衰竭。我们研究了早期高血压和泌尿系统事件对发生肾衰竭风险的纵向影响。

结果

ADPKD诊断时的中位年龄为22.3岁(四分位间距,16.5 - 28.6),肾衰竭的中位年龄为35.6岁(31.7 - 38.0)。68.1%的病例观察到高血压,早发性高血压在那些向肾衰竭加速进展的患者中更为常见。60.1%的病例存在泌尿系统事件,肉眼血尿负担较高(30.4%)。现有的ADPKD队列的平均年龄为45.5岁,高血压加权患病率为71.1%,肾结石为22.4%,血尿为22.9%,尿路感染为22.8%。与其他ADPKD队列相比,肾外表现较少见。

结论

本研究概述了一组疾病进展加速、40岁前达到肾衰竭的ADPKD患者。高血压和泌尿系统事件在年轻时高度流行,强调了早期和定期血压监测的重要性。

相似文献

1
Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40.40岁前发展至肾衰竭的常染色体显性多囊肾病患者的特征
Pediatr Nephrol. 2025 Jun;40(6):1997-2007. doi: 10.1007/s00467-024-06652-7. Epub 2025 Feb 1.
2
Polycystic Kidney Disease, Autosomal Dominant常染色体显性多囊肾病
3
The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease.一种继发性、罕见、非致病性PKD1变异对常染色体显性多囊肾病疾病进展的影响。
J Nephrol. 2025 Jan 30. doi: 10.1007/s40620-025-02211-x.
4
Autosomal Dominant Polycystic Kidney Disease: A Review.常染色体显性多囊肾病:综述
JAMA. 2025 May 20;333(19):1708-1719. doi: 10.1001/jama.2025.0310.
5
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.用于预防常染色体显性遗传性多囊肾病进展的干预措施。
Cochrane Database Syst Rev. 2024 Oct 2;10(10):CD010294. doi: 10.1002/14651858.CD010294.pub3.
6
Mortality risk in patients with autosomal dominant polycystic kidney disease.常染色体显性遗传多囊肾病患者的死亡风险。
BMC Nephrol. 2024 Feb 16;25(1):56. doi: 10.1186/s12882-024-03484-3.
7
The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression.疾病严重程度标志物对常染色体显性多囊肾病患者生活质量的影响:一项系统评价、荟萃分析和荟萃回归分析
BMC Nephrol. 2017 May 25;18(1):169. doi: 10.1186/s12882-017-0578-6.
8
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.预防常染色体显性多囊肾病进展的干预措施。
Cochrane Database Syst Rev. 2015 Jul 14;2015(7):CD010294. doi: 10.1002/14651858.CD010294.pub2.
9
MicroRNA and renal fibrosis in autosomal dominant polycystic kidney disease: a longitudinal study.微小RNA与常染色体显性多囊肾病中的肾纤维化:一项纵向研究
J Nephrol. 2025 Jan;38(1):153-162. doi: 10.1007/s40620-024-01965-0. Epub 2024 Jul 5.
10
Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis.常染色体显性多囊肾病中的高血压:一项荟萃分析。
Arch Dis Child. 2016 Dec;101(12):1142-1147. doi: 10.1136/archdischild-2015-310221. Epub 2016 Jun 10.

本文引用的文献

1
Clinical Characteristics of Rapid Progression in Asia-Pacific Patients With ADPKD.亚太地区常染色体显性多囊肾病患者快速进展的临床特征
Kidney Int Rep. 2023 Jun 26;8(9):1801-1810. doi: 10.1016/j.ekir.2023.06.018. eCollection 2023 Sep.
2
Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease.某些丝氨酸/苏氨酸激酶 NEK8 激酶结构域中的杂合变体可导致常染色体显性多囊肾病。
Kidney Int. 2023 Nov;104(5):995-1007. doi: 10.1016/j.kint.2023.07.021. Epub 2023 Aug 19.
3
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD.
序曲:一项关于常染色体显性多囊肾病患者疾病特征的全球前瞻性观察性研究。
Kidney Int Rep. 2023 Feb 13;8(5):989-1001. doi: 10.1016/j.ekir.2023.02.1073. eCollection 2023 May.
4
Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry.基于 3D 超声体积测量的儿童常染色体显性遗传性多囊肾病严重程度风险模型
Clin J Am Soc Nephrol. 2023 May 1;18(5):581-591. doi: 10.2215/CJN.0000000000000122. Epub 2023 Feb 17.
5
Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial.托伐普坦治疗常染色体显性遗传多囊肾病患儿和青少年患者的随机对照试验
Clin J Am Soc Nephrol. 2023 Jan 1;18(1):36-46. doi: 10.2215/CJN.0000000000000022.
6
Individuals heterozygous for ALG8 protein-truncating variants are at increased risk of a mild cystic kidney disease.杂合 ALG8 蛋白截断变异的个体患轻度囊性肾病的风险增加。
Kidney Int. 2023 Mar;103(3):607-615. doi: 10.1016/j.kint.2022.11.025. Epub 2022 Dec 24.
7
Hypertension in children and adolescents.儿童和青少年高血压。
Eur Heart J. 2022 Sep 14;43(35):3290-3301. doi: 10.1093/eurheartj/ehac328.
8
Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective.常染色体显性遗传性多囊肾病与心血管疾病的关联:美国全国住院患者视角。
Clin Exp Nephrol. 2022 Jul;26(7):659-668. doi: 10.1007/s10157-022-02200-5. Epub 2022 Feb 25.
9
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.单等位基因 IFT140 致病性变异是常染色体显性多囊肾病谱表型的一个重要原因。
Am J Hum Genet. 2022 Jan 6;109(1):136-156. doi: 10.1016/j.ajhg.2021.11.016. Epub 2021 Dec 9.
10
Overweight and Obesity and Progression of ADPKD.超重和肥胖与 ADPKD 的进展。
Clin J Am Soc Nephrol. 2021 Jun;16(6):908-915. doi: 10.2215/CJN.16871020. Epub 2021 Jun 11.